Latest news
This Week’s CGT News: Gene-Editing Trial Death Raises Concerns - The Medicine MakerThe Medicine Maker · Mon, 03 Aug 2026 11:24:02 GMTCapricor Therapeutics Faces Class Action Investigation After FDA Data Concerns Trigger 64% Stock Collapse - Azat TVAzat TV · Sun, 02 Aug 2026 17:15:00 GMTCAPR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Capricor (CAPR) - Business WireBusiness Wire · Fri, 31 Jul 2026 07:00:00 GMTCapricor Provides Update on Deramiocel for DMD Ahead of FDA Meeting - Intellectia AIIntellectia AI · Fri, 31 Jul 2026 07:00:00 GMTCapricor plummets after FDA panel votes against Duchenne heart disease therapy - ReutersReuters · Thu, 30 Jul 2026 07:00:00 GMTFDA Advisory Committee Votes Against Deramiocel for DMD Cardiomyopathy - NeurologyLiveNeurologyLive · Wed, 29 Jul 2026 07:00:00 GMTFDA adcomm shoots down Capricor's Duchenne cell therapy after meeting marked by statistical dispute - Fierce BiotechFierce Biotech · Wed, 29 Jul 2026 07:00:00 GMTFDA panel votes against Capricor's Duchenne heart disease therapy - ReutersReuters · Wed, 29 Jul 2026 07:00:00 GMT